Methotrexate compared with acitretin for widespread lichen planus
Compares methotrexate and acitretin tablets in adults with generalized lichen planus.
Key facts
- Who runs it
- Sheikh Zayed Medical College
- Where
- Pakistan1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Systemic Treatment Options for Generalized Lichen Planus
- Status
- Not yet recruiting
- Phase
- Phase 2
- People taking part
- 124 people, planned
- Started
- 10 Dec 2024
- Planned end
- 20 Mar 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Methotrexate (drug)
- Acitretin
- Record updated
- 18 December 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with generalized lichen planus, a long-lasting skin inflammation spread over the body. It compares oral methotrexate with oral acitretin.
- Age
- 18 to 60 years
- Sex
- Men and women
- Disease stage
- Generalized lichen planus
- Earlier treatment
- People cannot have taken treatment in the last 1 month.
Main reasons for not taking part
- Pregnant or breastfeeding women
- Bleeding disorders
- Abnormal liver function tests or platelet count less than 100000
- Allergy to Methotrexate or Acitretin
- Unrealistic expectations
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Age: 18-60 years
- Gender: both male and female
- Type of Lichen planus: generalized lichen planus
- Patients not taking prior treatment in last 1 month
Who cannot take part
- Bleeding disorders
- Hypersensitivity to Methotrexate or Acitretin
- Platelet count less than 100000
- Pregnancy and lactating females
- Abnormal liver function tests
- Unrealistic expectations
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Lichen planus is a chronic inflammatory skin condition with unknown etiology. It requires a long term treatment. Evaulating the most efficacious, safe and affordable treatment option is the need of the hour. This study is going to compare the efficacy of two familiar drugs (acitretin and methotrexate) in the treatment of generalized lichen planus as to find out the relatively more effective and safer treatment.
The 2 groups in the trial
- Oral methotrexate group (Group A)Existing treatment, for comparison
Patients with generalized lichen planus will be given 10 mg per week
Treatment: Methotrexate (drug)
- Oral Acitretin group (Group B)Existing treatment, for comparison
Patients with generalized lichen planus will be given oral acitretin 50 mg once daily
Treatment: Acitretin
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison of Efficacy of Oral Methotrexate and Acitretin for Generalized Lichen Planus
- Plain-language title
- Methotrexate compared with acitretin for widespread lichen planusGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06739551, who can take part
- Record updated
- 18 December 2024